Coronary CTA for Radiation Therapy Planning in Lymphoma Patients

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-002308
    Sponsor Protocol Number: 14-002308

About this study

Our purpose for this study is to help design a therapy plan that can decrease extra radiation exposure to your heart during radiotherapy. The therapy plan will use images obtained using a dual-source CT scanner

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion criteria:

  • Patients between 7 and 65 years of age with a confirmed diagnosis of Hodgkin or non-Hodgkin lymphoma involving the mediastinum who are scheduled for radiotherapy

  • Written informed consent signed.For pediatric patients, the consent form has to be signed by parent or guardian

  • Is not pregnant for female patients of childbearing age

Exclsuion Criteria:

  •   Severe renal insufficiency, defined as a serum creatinine >1.9 mg/dL

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eric Williamson, M.D.

Open for enrollment

Contact information:

Eric Williamson M.D.

(507)284-1728

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions